Technical Analysis for 0RQJ - Saniona AB
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 1.76 | -5.67% | -0.11 |
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | N/A | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| New 52 Week Closing Low | Bearish | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.00% | |
| New 52 Week Low | Weakness | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Gapped Down | Weakness | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Volume Surge | Other | -5.67% | |
| Narrow Range Bar | Range Contraction | -5.67% | |
| Outside Day | Range Expansion | -5.67% | |
| Wide Bands | Range Expansion | -5.67% |
Get a Trading Sidekick!
Saniona AB Description
Saniona AB (publ), a biopharmaceutical company, engages in the research, development, and commercialization of treatments for rare disease patients in Denmark. It also develops medicines modulating ion channels. The company's products include Tesofensine, a monoamine reuptake inhibitor; and Tesomet, a fixed dose combination of tesofensine and metoprolol that has completed the Phase 2 clinical trials for the treatment of prader-willi syndrome and hypothalamic obesity. It also develops SAN711, which has completed Phase 1 clinical stage for neuropathic pain conditions; SAN903 for inflammatory and fibrotic disorders; and SAN2219, that is in preclinical stage for treatment of epilepsy. The company has research and collaboration agreements with Boehringer Ingelheim International GmbH; license agreement with Productos Medix, S.A. de C.V.; research services agreement and a collaboration agreement with Cephagenix ApS; and research collaboration with AstronauTx to identify new treatments for Alzheimer's disease. Saniona AB (publ) was founded in 2011 and is headquartered in Glostrup, Denmark.
Classification
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 12.38 |
| 52 Week Low | 1.762 |
| Average Volume | 2,534 |
| 200-Day Moving Average | 0.00 |
| 50-Day Moving Average | 4.86 |
| 20-Day Moving Average | 3.03 |
| 10-Day Moving Average | 2.17 |
| Average True Range | 0.26 |
| RSI (14) | 3.85 |
| ADX | 38.0 |
| +DI | 21.31 |
| -DI | 69.88 |
| Chandelier Exit (Long, 3 ATRs) | 5.16 |
| Chandelier Exit (Short, 3 ATRs) | 2.53 |
| Upper Bollinger Bands | 4.98 |
| Lower Bollinger Band | 1.07 |
| Percent B (%b) | 0.18 |
| BandWidth | 128.98 |
| MACD Line | -1.00 |
| MACD Signal Line | -0.92 |
| MACD Histogram | -0.0781 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 1.76 | ||||
| Resistance 3 (R3) | 1.76 | 1.76 | 1.76 | ||
| Resistance 2 (R2) | 1.76 | 1.76 | 1.76 | 1.76 | |
| Resistance 1 (R1) | 1.76 | 1.76 | 1.76 | 1.76 | 1.76 |
| Pivot Point | 1.76 | 1.76 | 1.76 | 1.76 | 1.76 |
| Support 1 (S1) | 1.76 | 1.76 | 1.76 | 1.76 | 1.76 |
| Support 2 (S2) | 1.76 | 1.76 | 1.76 | 1.76 | |
| Support 3 (S3) | 1.76 | 1.76 | 1.76 | ||
| Support 4 (S4) | 1.76 |
